Log on / register
Feedback | Support | My details
A randomized, double-blind comparison of OROS(R) hydromorphone and controlled-release morphine for the control of chronic cancer pain.
Hanna M, Thipphawong J, 118 Study Group
BMC Palliat Care 2008, 7:17
[Full text] [PubMed] [Related articles]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article
An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS® hydromorphone in patients with chronic cancer pain
Hanna M, Tuca A, Thipphawong J
BMC Palliative Care 2009, 8:14 (15 September 2009)
[Full text] [PubMed Central] [PubMed] [Related articles]
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.